Small Molecule Antivirals

Creative Diagnostics offers a variety of anti-infection compounds with robust antiviral biological activity. As a vital tool in the arsenal of drug discovery, compound libraries determine the speed and quality of small-molecule drug development. These compounds are tailored to combat a spectrum of pathogens including SARS-CoV-2, MERS-CoV, Influenza Virus, CMV, HSV, HIV, HBV, and more. Furthermore, given the potential structural congruence with viral targets, the prospect of compound-driven antiviral efficacy is substantially bolstered.